Gina Schweizer

Gina Schweizer is an experienced professional in strategy operations, clinical reporting, and medical writing, currently serving as Vice President and Head of Strategy Operations and Clinical Reporting & Transparency at Genmab since October 2018, after holding multiple leadership roles within the same company. Before joining Genmab, Gina Schweizer worked at Janssen, Pharmaceutical Companies of Johnson and Johnson as Associate Director of Regulatory Medical Writing from May 2005 to October 2018, and at Merck as Senior Regulatory Specialist in Worldwide Regulatory Operations from January 2000 to May 2005. Gina Schweizer holds a Master of Business Administration (MBA) in Pharmaceutical and Healthcare Business and a Master of Science (MS) in Biomedical Writing from the University of the Sciences in Philadelphia, along with a Bachelor's Degree from Indiana University of Pennsylvania. Since January 2024, Gina Schweizer has also been a Chief Member at Chief.